Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al

Affiliations

¹ James Chih-Hsin Yang, National Taiwan University Hospital, Taipei, Taiwan; Tarun Puri, Eli Lilly, Gurgaon, Haryana, India; Mauro Orlando, Eli Lilly Interamérica, Buenos Aires, Argentina; and Ying Cheng, Jilin Provincial Cancer Hospital, Changchun, China.

Comment

James Chih-Hsin Yang et al. J Clin Oncol. 2017.

. 2017 Feb 20;35(6):694-695.

doi: 10.1200/JCO.2016.70.6978. Epub 2016 Dec 5.

¹ James Chih-Hsin Yang, National Taiwan University Hospital, Taipei, Taiwan; Tarun Puri, Eli Lilly, Gurgaon, Haryana, India; Mauro Orlando, Eli Lilly Interamérica, Buenos Aires, Argentina; and Ying Cheng, Jilin Provincial Cancer Hospital, Changchun, China.

No abstract available

Comment on

Randomized Phase II Trial of Gefitinib With and Without Pemetrexed as First-Line Therapy in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations.
Cheng Y, Murakami H, Yang PC, He J, Nakagawa K, Kang JH, Kim JH, Wang X, Enatsu S, Puri T, Orlando M, Yang JC. Cheng Y, et al. J Clin Oncol. 2016 Sep 20;34(27):3258-66. doi: 10.1200/JCO.2016.66.9218. Epub 2016 Aug 9. J Clin Oncol. 2016. PMID: 27507876 Clinical Trial.
Gefitinib Plus Pemetrexed As First-Line Treatment in Patients With Nonsquamous Non-Small-Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Mutations.
Kim YH. Kim YH. J Clin Oncol. 2017 Feb 20;35(6):692. doi: 10.1200/JCO.2016.70.2472. Epub 2016 Dec 5. J Clin Oncol. 2017. PMID: 27918713 No abstract available.
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Chemotherapy: A Glimmer of Hope?
Van Der Steen N, Rolfo CD, Pauwels P, Peters GJ, Giovannetti E. Van Der Steen N, et al. J Clin Oncol. 2017 Feb 20;35(6):692-693. doi: 10.1200/JCO.2016.70.1987. Epub 2016 Dec 5. J Clin Oncol. 2017. PMID: 27918717 No abstract available.
Unconvincing Benefit of Combination Therapy With Gefitinib and Pemetrexed in Advanced Non-Small-Cell Lung Cancer.
Ota A, Gyawali B, Matsuoka A, Ando Y. Ota A, et al. J Clin Oncol. 2017 Feb 20;35(6):691-692. doi: 10.1200/JCO.2016.70.4148. Epub 2016 Dec 5. J Clin Oncol. 2017. PMID: 27918721 No abstract available.